NewAmsterdam Pharma Co N.V.
NAMSReported to SECin USCIK 0001936258Filings at SEC EDGAR
NAMS is one of 2 listed share classes under this CIK; the filings below cover all of them.
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 14. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Davidson Michael H.Chief Executive Officer | Open-market buy | $226,50010,000 shares | Sep 15, 2026 | Davidson Michael H.Chief Executive Officer | $226,500 | Open-market buy | 10,000 | Sep 15, 2026 |
| Smither John W— | Open-market sell | $40,5121,600 shares | Sep 9, 2026 | Smither John W | $40,512 | Open-market sell | 1,600 | Sep 9, 2026 |
| Gunning Robert WilliamVice President, Controller | Award | nothing paid14,000 shares | Sep 3, 2026 | Gunning Robert WilliamVice President, Controller | nothing paid | Award | 14,000 | Sep 3, 2026 |
| Gunning Robert WilliamVice President, Controller | Award | nothing paid3,200 shares | Sep 3, 2026 | Gunning Robert WilliamVice President, Controller | nothing paid | Award | 3,200 | Sep 3, 2026 |
| Kastelein Johannes Jacob PieterChief Scientific Officer | Option exercise | nothing paid125,000 shares | Aug 25, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | nothing paid | Option exercise | 125,000 | Aug 25, 2026 |